[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "MAT2A",
            "9p21",
            "CDKN2A",
            "MTAP",
            "Solid Tumors",
            "PRMT5",
            "SAM",
            "Synthetic Lethality",
            "Inhibitor",
            "MTAP deletion",
            "CDKN2A deletion",
            "MAT2A Inhibitor",
            "Advanced solid tumors",
            "Lung Cancer",
            "Pancreatic or Pancreas Cancer",
            "Bladder Cancer",
            "Renal Cancer",
            "Mesothelioma",
            "Esophageal Cancer",
            "Head and Neck Squamous Cell Carcinoma",
            "Gastric Cancer",
            "Breast cancer",
            "Melanoma",
            "Cholangiocarcinoma"
        ],
        "dcp_id": null,
        "interventional_model": "SEQUENTIAL_ASSIGNMENT",
        "lead_org": "IDEAYA Biosciences",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Participant must be at least 18 years of age"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Advanced or metastatic solid tumor that has progressed on at least one prior line of treatment or is intolerant to additional effective standard therapy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Have evidence of homozygous loss of MTAP or MTAP deletion at the DNA or protein level in the participant's tumor tissue"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Measurable disease"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "ECOG performance status <= 1 or 2"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Adequate organ function"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Able to swallow and retain orally administered study treatment"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Able to comply with contraceptive/barrier requirements"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 8,
                    "description": "Known symptomatic brain metastases that are not neurologically stable for 3 months"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 9,
                    "description": "Known primary CNS malignancy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 10,
                    "description": "Current active liver or biliary disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 11,
                    "description": "Active inflammatory gastrointestinal disease, chronic diarrhea, known diverticular disease or previous gastric resection or lap band surgery"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 12,
                    "description": "Impairment of gastrointestinal (GI) function or GI disease that may significantly alter the absorption of IDE397"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "Active, uncontrolled infection including hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or acquired immunodeficiency syndrome related illness"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Baseline 12 lead ECG that demonstrates clinically relevant abnormalities"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Clinically significant cardiac events 6 months before study entry"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "Uncontrolled hypertension despite optimal medical therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Previous treatment with a MAT2A inhibitor and / or PRMT inhibitor"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Major surgery within 4 weeks prior to C1D1"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Radiation therapy within 4 weeks prior to C1D1"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "Systemic anti-cancer therapy (non-monoclonal antibody) within 4 weeks prior to study entry or within 28 days prior to study entry for an antibody based agent(s) or 5 half-lives (whichever is shorter)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Have received radioimmunotherapy less than 6 weeks before the first dose of IDE397"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Have received treatment with a therapeutic antibody less than 4 weeks before the first dose of IDE397"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Have received treatment with an investigational small molecule less than 2 weeks before the first dose of IDE397"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Prior irradiation to >25% of the bone marrow"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Current use or anticipated need for food or drugs that are known strong CYP3A4/5 inhibitors"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Current use or anticipated need for food or drugs that are known strong CYP3A4/5 inducers"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "Received an investigational product within 28 days prior to first dose of IDE-397 or 5 half-lives (whichever is shorter)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "Exposure to more than 4 investigational medicinal products within 12 months prior to C1D1"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "Known or suspected hypersensitivity to IDE397/excipients or components"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "An Open Label, Phase 1, Treatment Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of IDE397 (MAT2A Inhibitor) In Adult Participants With Advanced Solid Tumors",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "21 days following the first dose of IDE397",
                "name": "Dose-limiting Toxicities (DLTs) of IDE397",
                "description": "Incidence of DLTs of IDE397 will be determined",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Maximum Tolerated Dose (MTD) and/or Recommended Phase 2 Dose (RP2D) of IDE397",
                "description": "MTD and RP2D of IDE397 will be determined",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Pharmacodynamic effect of IDE397",
                "description": "Changes in the levels of MAT2A pathway (SAM and MAT2A) and PRMT5 pathway (SDMA) will be determined",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Plasma Pharmacokinetics of IDE397 and metabolite",
                "description": "Pharmacokinetics of IDE397 and metabolite following single and multiple oral administration will be determined",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Approximately 2 years",
                "name": "Preliminary anti-tumor activity",
                "description": "Objective response rate and duration of response will be assessed using the Response Evaluation Criteria in Solid Tumors (RECIST v1.1)",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 1,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04794699",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Aberrant Chromosome 9",
                    "Chromosome 9 Aberration"
                ],
                "nci_thesaurus_concept_id": "C180942",
                "name": "Chromosome 9 Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C2950",
                    "C3910"
                ],
                "parents": [
                    "C2950"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Anomaly",
                    "DNA Sequence Variation",
                    "Genetic Abnormality",
                    "Genetic Alteration",
                    "Genetic Anomaly",
                    "Molecular Abnormality",
                    "Molecular Anomaly",
                    "Molecular Genetic Abnormality",
                    "Molecular Genetic Anomaly"
                ],
                "nci_thesaurus_concept_id": "C36391",
                "name": "Molecular Genetic Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C97926"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Deletion",
                    "Deletion Abnormality",
                    "Mutation, Deletion",
                    "del"
                ],
                "nci_thesaurus_concept_id": "C19296",
                "name": "Deletion Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36541",
                    "C36391",
                    "C2950",
                    "C133155",
                    "C97926",
                    "C45576",
                    "C36327",
                    "C3910"
                ],
                "parents": [
                    "C133155",
                    "C45576"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "VARIANT_TYPE",
                    "molecular consequence",
                    "molecular_consequence"
                ],
                "nci_thesaurus_concept_id": "C97926",
                "name": "Molecular Sequence Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3910"
                ],
                "parents": [
                    "C3910"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Chromosomal Rearrangements",
                    "Rearrangement",
                    "Structural Chromosomal Abnormality",
                    "Structural Chromosome Aberration",
                    "Structural Chromosome Anomalies"
                ],
                "nci_thesaurus_concept_id": "C36541",
                "name": "Chromosomal Rearrangement",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3910",
                    "C2950"
                ],
                "parents": [
                    "C2950"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Chromosomal, Gene, or Protein Abnormality",
                    "Cytogenetic or Molecular Genetic Abnormality",
                    "Genetic Abnormality",
                    "MOLECULAR_ABNORMALITY",
                    "Molecular Alteration"
                ],
                "nci_thesaurus_concept_id": "C3910",
                "name": "Molecular Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genetic Alteration",
                    "Genetic Change",
                    "Mutated",
                    "Mutation"
                ],
                "nci_thesaurus_concept_id": "C45576",
                "name": "Mutation Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36391",
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Gene Deletion Mutation",
                    "Transcript Ablation"
                ],
                "nci_thesaurus_concept_id": "C16606",
                "name": "Gene Deletion",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36541",
                    "C36391",
                    "C2950",
                    "C133155",
                    "C97926",
                    "C45576",
                    "C36327",
                    "C3910",
                    "C19296"
                ],
                "parents": [
                    "C19296"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "5'-Methylthioadenosine Phosphorylase Negative",
                    "MTA Phosphorylase Negative",
                    "MTAP Deficiency",
                    "MTAP Deficient",
                    "MTAP Loss",
                    "MTAP Null",
                    "MTAPase Negative",
                    "Methylthioadenosine Phosphorylase Loss",
                    "Methylthioadenosine Phosphorylase Negative",
                    "Methylthioadenosine Phosphorylase Null",
                    "S-Methyl-5'-Thioadenosine Phosphorylase Loss",
                    "S-Methyl-5'-Thioadenosine Phosphorylase Negative"
                ],
                "nci_thesaurus_concept_id": "C156051",
                "name": "MTAP Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C165233",
                    "C3367",
                    "C16612",
                    "C26147",
                    "C35681",
                    "C25870",
                    "C103994",
                    "C77140",
                    "C21281"
                ],
                "parents": [
                    "C103994",
                    "C165233"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36327",
                "name": "Gene Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36391",
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C26147",
                "name": "Glycosyltransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C21281"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "MSAP Gene Deletion",
                    "MTAP Deletion",
                    "Methylthioadenosine Phosphorylase Gene Deletion"
                ],
                "nci_thesaurus_concept_id": "C177782",
                "name": "MTAP Gene Deletion",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612",
                    "C36327",
                    "C2950",
                    "C26147",
                    "C3910",
                    "C19296",
                    "C133155",
                    "C25870",
                    "C45576",
                    "C97926",
                    "C103994",
                    "C16606",
                    "C36541",
                    "C36391",
                    "C21281",
                    "C180942"
                ],
                "parents": [
                    "C103994",
                    "C16606",
                    "C180942"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C35681",
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Abnormal Gene Rearrangement",
                    "Abnormal Rearrangement",
                    "Gene Rearrangement"
                ],
                "nci_thesaurus_concept_id": "C133155",
                "name": "Gene Rearrangement Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C36391",
                    "C2950",
                    "C97926",
                    "C3910",
                    "C36541",
                    "C36327"
                ],
                "parents": [
                    "C36327",
                    "C36541"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "MTAP",
                    "Methylthioadenosine Phosphorylase Gene"
                ],
                "nci_thesaurus_concept_id": "C103994",
                "name": "MTAP Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C25870",
                    "C16612",
                    "C21281",
                    "C26147"
                ],
                "parents": [
                    "C26147"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Aberrant Chromosome",
                    "Chromosomal Aberration",
                    "Chromosomal Abnormalities",
                    "Chromosomal Abnormality",
                    "Chromosomal Alterations",
                    "Chromosome Aberration",
                    "Chromosome Abnormality",
                    "Chromosome Alterations",
                    "Chromosome Anomalies",
                    "Cytogenetic Aberration",
                    "Cytogenetic Analysis Abnormality Type"
                ],
                "nci_thesaurus_concept_id": "C2950",
                "name": "Cytogenetic Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "eligibility_criteria": "inclusion",
                "ancestors": [
                    "C3910"
                ],
                "parents": [
                    "C3910"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2021-03-15",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Solid Tumor",
                    "Metastatic Tumor",
                    "Metastatic Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Advanced Malignant Solid Neoplasm",
                    "Advanced Non-Hematologic Malignancy",
                    "Advanced Solid Neoplasm",
                    "Advanced Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C129707",
                "name": "Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C127155",
                    "C9270"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, secondary",
                    "Secondary Tumor",
                    "Tumor, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Disease",
                    "Diseases and Disorders",
                    "disease type",
                    "Disease or Disorder",
                    "Diagnosis",
                    "disease_term",
                    "condition",
                    "disease_type",
                    "Diseases",
                    "Disease or Disorder, Non-Neoplastic",
                    "Disorders",
                    "Disorder"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Tumour",
                    "Solid tumor, NOS",
                    "Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasms, NOS",
                    "Neoplasia",
                    "Tumor, NOS",
                    "Neoplastic Growth",
                    "Neoplasm",
                    "Neoplastic Disease",
                    "tumor",
                    "Neoplasm, NOS"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Malignant Growth",
                    "Tumor, malignant, NOS",
                    "Malignant Tumor",
                    "Malignancy",
                    "CA",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Tumor",
                    "Tumor, metastatic",
                    "Neoplasm, metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Malignancy",
                    "Secondary Cancer"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C36255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "IDE397-001",
        "active_sites_count": 6,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Tumor Agents",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antiproliferative Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Anti-Tumor Drugs",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug",
                            "Pharmacologic Agent",
                            "Pharmaceuticals",
                            "Pharmaceutical Agent",
                            "Agent",
                            "Drug Substance",
                            "Pharmacological Substance"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Protein Inhibitor",
                            "Antineoplastic Protein Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Drug",
                            "Enzyme Inhibitor Agent"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C153180",
                        "name": "MAT2A Inhibitor AG-270",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129825"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Dose Escalation Monotherapy",
                "description": "IDE397 dosed orally, once daily (QD) for each 21-day cycle",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2021-06345",
        "why_study_stopped": null,
        "brief_summary": "This is a Phase 1, open-label, multicenter, multiple dose, dose escalation study of the\r\n      safety, PK, PD, and anti-tumor activity of IDE397 as a single agent in adult patients with\r\n      selected advanced or metastatic MTAP-deleted advanced solid tumors who are unresponsive to\r\n      standard of care therapy or for whom no curative therapy is available.",
        "brief_title": "Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion",
        "status_history": [
            {
                "status_date": "2021-03-15T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 40,
        "_current_trial_status_sort_order": 0,
        "start_date": "2021-04-14",
        "record_verification_date": "2021-06-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "NA"
        },
        "acronym": null,
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2024-12-31",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]